Viewing Study NCT02659293


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-01-04 @ 4:41 PM
Study NCT ID: NCT02659293
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-23
First Post: 2016-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Sponsor: University of Chicago
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module